Delivery Order SPE2DB20D3303-SPE2DB25FZ3E7
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB20D3103|SPE2DB25FM3T6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, and has a ceiling value of $1,212.51. It is a Firm Fixed Price Delivery Order contract with a performance period ending on January 21, 2025. The contract is not designated as a...
This federal contract award, with a total ceiling value of $1,226.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is January 23, 2023. The award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, valued at $5,667.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a medical product, with an ultimate completion date of November 4, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,120.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order that provides SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.09 firm fixed-price delivery order contract is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product. The contract has a period of performance through September 9, 2024 and was awarded on September 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,372.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 14, 2023. This award is part of a larger...
This federal contract award, with ID SPE2DB22D1202|SPE2DB23FJBY5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,400.61 Firm Fixed Price Delivery Order contract is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a ceiling value of $2,176.55 and a completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,944.43, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,663.96, is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...